🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the study is to evaluate whether the TEP-CT can be sensitive and...
Status
Completed
Location
CHU Nord
Start Date
2011-01
Trial ID
NCT01485679
Treatments Being Tested
This phase II trial tests the accuracy of functional imaging (FFNP)-positro...
Status
Recruiting
Location
Siteman Cancer Center at Washington University
Start Date
2024-07-22
Trial ID
NCT06179303
Treatments Being Tested
MIGAT will develop and transfer software tools to assist ablation therapy o...
Status
Completed
Location
Hôpital cardiologique du Haut-Lévêque
Start Date
2014-09-01
Trial ID
NCT02275104
* The goal of this study is to determine the feasibility of the diffusion w...
Status
Unknown
Location
Multiple Locations
Start Date
2019-09-01
Trial ID
NCT03969381
Treatments Being Tested
This phase II trial studies the side effects of chemotherapy and intensity ...
Status
Active Not Recruiting
Location
Zuckerberg San Francisco General Hospital
Start Date
2022-08-09
Trial ID
NCT04929028
Treatments Being Tested
This is a single arm, phase 0 study to evaluate the safety and efficacy of ...
Status
Withdrawn
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2020-12
Trial ID
NCT03295695
Positron emission tomography (PET) is a nuclear medicine procedure based on...
Status
Completed
Location
BCCA, Vancouver Centre
Start Date
2005-06
Trial ID
NCT00207298
Treatments Being Tested
This clinical trial studies positron emission tomography imaging in using c...
Status
Terminated
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT02810873
This clinical trial examines positron emission tomography (PET)/computed to...
Status
Recruiting
Location
Thomas Jefferson University Hospital
Start Date
2023-01-20
Trial ID
NCT05775939
Alzheimer's disease (AD) is characterized by neuritic plaques, neurofibrill...
Status
Terminated
Location
University of Utah
Start Date
2009-11
Trial ID
NCT00811122
Treatments Being Tested